Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Die Anaesthesiologie|December 16, 2024
[Post-Intensive Care Syndrome: functional impairments of critical illness survivors]Nicolas Paul, Björn Weiss
Journal of Clinical Medicine|October 27, 2022
Post-Intensive Care Syndrome after Critical Illness: An Imperative for Effective PreventionNicolas Paul, Björn Weiss
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 2, 2008
The cost of radiation therapyNicolas Paul Ploquin, Peter Brian Dunscombe
Health Data Science|March 15, 2024
A Framework for Assessing Import Costs of Medical Supplies and Results for a Tuberculosis Program in Karakalpakstan, UzbekistanStefan Kohler, Norman Sitali, Nicolas Paul
PLOS Global Public Health|April 2, 2024
Correction: The contribution of drug import to the cost of tuberculosis treatment: A cost analysis of longer, shorter, and short drug regimens for Karakalpakstan, UzbekistanStefan Kohler, Norman Sitali, Jay Achar, et al.
PLOS Global Public Health|March 24, 2023
The contribution of drug import to the cost of tuberculosis treatment: A cost analysis of longer, shorter, and short drug regimens for Karakalpakstan, UzbekistanStefan Kohler, Norman Sitali, Jay Achar, et al.
ERJ Open Research|March 30, 2022
Programme costs of longer and shorter tuberculosis drug regimens and drug import: a modelling study for Karakalpakstan, UzbekistanStefan Kohler, Norman Sitali, Jay Achar, et al.
Journal of Public Health (Oxford, England)|November 23, 2022
Costs and import costs of past, present, and future TB drug regimens: a case study for Karakalpakstan, UzbekistanStefan Kohler, Norman Sitali, Jay Achar, et al.
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|January 7, 2021
[Avoiding Long-term Impairment in Critical Care Using Telemedicine: The ERIC Example]Björn Weiss, Nicolas Paul, Ben Kraufmann, et al.
Globalization and Health|June 25, 2024
Trends in the availability and prices of quality-assured tuberculosis drugs: a systematic analysis of Global Drug Facility Product Catalogs from 2001 to 2024Stefan Kohler, Jay Achar, Christiaan Mulder, et al.
Pageof 4